In a pioneering discovery, Huntsman Cancer Institute researchers have found that obesity may increase breast cancer risk by removing a natural defense found in the fat cells of non-obese individuals.
Huntsman Cancer Institute marks a major construction milestone for its Vineyard campus that will bring hope and healing closer to patients and families in Utah County and the Mountain West.
Huntsman Cancer Institute performed the Mountain West's first robotic mastectomy surgery, offering eligible breast cancer patients less visible scarring, faster recovery, and improved cosmetic outcomes.
National honors spotlight exceptional cancer care, research, nursing excellence, and healing-centered facilities—showing how innovation and excellence are improving outcomes for patients and families.
Research highlights include advancements in theranostics, a clinical trial in prostate cancer, the Hedgehog signaling pathway, cutting off tumor growth, and how older adults consume low-credibility health information.
Seven Huntsman Cancer Institute researchers receive first-time, new, or renewed endowed chair appointments, honoring scientific achievement and providing vital support to strengthen research programs and advance progress in cancer discovery.
Researchers found the revolutionary drug daraxonrasib could be effective against an aggressive type of skin cancer, offering hope for patients with advanced disease who currently lack effective targeted options.
Orly Alter, PhD, developed a quantum mechanics–based AI method that analyzes molecular features to improve outcome predictions, identify drug targets, and advance personalized cancer treatment and drug development.
Two physician-scientists at Huntsman Cancer Institute have been named 2026 Translational Scholars, recognizing their leadership in advancing translational research that brings scientific discoveries to cancer patients faster.
Our leaders, researchers, and physicians are shaping the future of oncology through groundbreaking discoveries and transformative contributions. These are some of the highlights of prestigious national awards and appointments.
Karen Huntsman helped build a movement against cancer—one defined by compassion, vision, and hope. Her legacy will continue to shape care, research, and the lives of patients and families.
In Southeast Idaho, a new affiliation brings advanced clinical expertise, research, and treatment options closer to home for these patients and families.
A clinical trial led by Neeraj Agarwal, MD, FASCO, found that a combination prostate cancer therapy could slow disease progression for patients with certain gene alterations, including BRCA.
From the seat of an excavator, cancer survivor Noah Reeb officially broke ground on an expansion that will double capacity, bring lifesaving care closer to home, and advance research, education...
What if cancer cells are using a signaling shortcut we’ve been missing? Scientists uncovered a mechanism in a key cell-to-cell communication system—insight that could point to more effective therapies.
Utah’s $33 million investment fuels AI, advanced computing, and secure data innovation—strengthening health research and discovery statewide through leadership at the University of Utah and Huntsman Cancer Institute.
The first three patients have been treated in an early-stage clinical trial of a new radiopharmaceutical medicine at Huntsman Cancer Institute, marking an important step in developing new cancer therapies.
Researchers developed a chip-based platform, “μPharma,” that rapidly predicts drug response through AI analysis for children with T-ALL, potentially enabling clinicians to make faster, personalized treatment decisions.
A Huntsman Cancer Institute researcher evaluated a noninvasive skin imaging technology that accurately discriminates between common moles and melanoma, potentially enhancing melanoma screening while reducing the need for unnecessary biopsies.
Advancing detection of prostate cancer, a new imaging drug targets PSMA—a protein marking cancer cells—helping physicians identify disease earlier and guiding patients toward timely, confident treatment decisions.
A breakthrough clinical trial for a deadly brain tumor, how fatty acids affect breast cancer risk, upending our ideas about melanoma’s origins, and a new drug for sarcoma patients.
Leaders at Huntsman Cancer Institute are shaping the future of oncology through groundbreaking research, influential roles, and transformative contributions recognized by prestigious national awards and appointments.
